Cancer Biology Program in the department of Pediatrics
Research Interests
  • » Michael Cleary, MD
    Research interests focus on the molecular pathogenesis of acute leukemias. His laboratory group has discovered several of the major cancer genes that are mutated in childhood leukemias.
  • » Julien Sage, PhD
    Research in the Sage laboratory focuses on the retinoblastoma tumor suppressor gene (RB).
  • » Alejandro Sweet-Cordero, MD
    The two most frequent bone sarcomas in children are Osteosarcoma and Ewing’s Sarcoma. Our laboratory is interested in understanding the cell of origin of these tumors.


Pediatric Cancer Biology Program
Mike Cleary, MD
Michael Cleary, MD

The overall research goals of the program are to elucidate the molecular pathogenesis of pediatric cancers and to translate this knowledge into improved treatments. This long-term objective has three major components. The first is to identify the molecular aberrations that induce and sustain the aberrant growth of pediatric cancers. The second is to elucidate the molecular mechanisms by which these aberrations disrupt normal growth control processes. The third is to design therapies that specifically target these molecular abnormalities for treatment of children with cancer and to devise new molecular tools for monitoring the response to therapy in real time.

Center of Excellence
Michael Link, MDThe Bass Center of Excellence in Pediatric Cancer & Blood Diseases is committed to outstanding clinical care and research for children with cancer. Our faculty consists of physicians and scientists who work on all forms of pediatric cancer and who are part of a larger community of scientists at Stanford University. Our training programs in clinical oncology and hematology and in cancer research train the next generation of leaders in the field. More »

Footer Links: